FDA Granted Orphan Drug Status To Nitric Oxide As Potential IPF Treatment
Senior Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses how the FDA granted orphan drug status to nitric oxide as a potential IPF treatment.
Are you interested in learning more about Pulmonary Fibrosis? If so, please visit pulmonaryfibrosisnews.com/
What do you think about this news? Listen to this flash briefing episode and share your thoughts in the comment section below!
Log in to reply.